Out of Control: The Urgent Need for Cannabis Regulation and Regulatory Science скачать в хорошем качестве

Out of Control: The Urgent Need for Cannabis Regulation and Regulatory Science

Dr. Budney will discuss the addictive potential and adverse consequences of THC-laden cannabis use in parallel with a discussion of the evidence for therapeutic potential of cannabis products. He will highlight the public health importance of developing more effective ways to communicate what is known about the effects of the myriad of cannabinoid products now available. A discussion of the roles of government and industry in shaping public perception of the risk and benefits of cannabis products will illustrate the urgent need for more effective cannabis regulation and much more cannabis regulatory science. Bio: Alan Budney is a clinical psychologist and Professor at the Geisel School of Medicine at Dartmouth where he directs a NIDA-funded training program on the Science of Co-Occurring Disorders and is Director of the Treatment Development and Evaluation Core of Dartmouth's Center for Technology and Behavioral Health. He has conducted extensive research on innovative behavioral treatments for Cannabis Use Disorders in adults and adolescents. This applied research focused on integrating contingency management interventions with more traditional behavioral therapies and using computer-assisted therapies to enhance access to and the cost effectiveness of these approaches. Dr. Budney also conducted seminal human laboratory and survey studies characterizing the cannabis withdrawal syndrome. Recently, his studies involve the use of social media to better understand the impact of changing cannabis laws and regulations, and the development of on-line applications of behavioral economic interventions to modify cannabis use. Dr. Budney is Past-President of Division 28 and Division 50 of the American Psychological Association and the College on Problems of Drug Dependence. He was a member of the DSM-5 Substance Use Disorders working group and consults and serves on multiple scientific advisory organizations related to cannabis consequences and therapeutics including the UCSD Center for Medical Cannabis Research.